Adiponectin acts as an endogenous antithrombotic factor. - Wikidata - wikimedia - TriplyDB

Adiponectin acts as an endogenous antithrombotic factor.

Adiponectin acts as an endogenous antithrombotic factor.

http://www.wikidata.org/entity/Q33226568

about

Adiponectin as a potential biomarker of vascular disease Adiponectin and leptin molecular actions and clinical significance in breast cancer The secret life of a megakaryocyte: emerging roles in bone marrow homeostasis control Adiponectin and cardiovascular disease: state of the art?Adiponectin resistance and vascular dysfunction in the hyperlipidemic state Serum adiponectin and cardiometabolic risk in patients with acute coronary syndromes.Potential novel biomarkers of cardiovascular dysfunction and disease: cardiotrophin-1, adipokines and galectin-3.Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.Younger age, higher body mass index and lower adiponectin concentration predict higher serum thromboxane B2 level in aspirin-treated patients with type 2 diabetes: an observational study.Morbid obesity and metabolic syndrome in Ossabaw miniature swine are associated with increased platelet reactivity.Adiponectin receptor 2 deficiency results in reduced atherosclerosis in the brachiocephalic artery in apolipoprotein E deficient mice The impact of gender and left atrial blood stasis on adiponectin levels in non-valvular atrial fibrillation.Adiponectin expression and the cardioprotective role of the vitamin D receptor activator paricalcitol and the angiotensin converting enzyme inhibitor enalapril in ApoE-deficient mice.Trans-fatty acid promotes thrombus formation in mice by aggravating antithrombogenic endothelial functions via Toll-like receptors.Vascular smooth muscle cell-derived adiponectin: a paracrine regulator of contractile phenotype.Adiponectin: an adipokine with protective features against metabolic syndrome.Adiponectin induces pro-inflammatory programs in human macrophages and CD4+ T cells Obesity, diabetes and atrial fibrillation; epidemiology, mechanisms and interventions.Reduction of CTRP9, a novel anti-platelet adipokine, contributes to abnormal platelet activity in diabetic animals.Targeting adiponectin for cardioprotection.Adipocytokine profile and insulin resistance in childhood obesity.Adiponectin inhibits macrophage tissue factor, a key trigger of thrombosis in disrupted atherosclerotic plaques.Adiponectin deficiency promotes endothelial activation and profoundly exacerbates sepsis-related mortality.Once fat was fat and that was that: our changing perspectives on adipose tissue.Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study Is adiponectin associated with acute myocardial infarction in Iranian non obese patients?Adiponectin promotes revascularization of ischemic muscle through a cyclooxygenase 2-dependent mechanism Immune and inflammatory mechanisms of atherosclerosis (*)Adiponectin treatment attenuates inflammatory response during early sepsis in obese mice.Relationship of plasma adiponectin levels with acute coronary syndromes and coronary lesion severity in north Indian population.Diabetes, Obesity and Atrial Fibrillation: Epidemiology, Mechanisms and Interventions The utility of physical activity in the management of global cardiometabolic risk.Total adiponectin is inversely associated with platelet activation and CHA₂DS₂-VASc score in anticoagulated patients with atrial fibrillation.Diabetes mellitus, inflammation, obesity: proposed treatment pathways for current and future therapies.PPARgamma activation: a potential treatment for pulmonary hypertension.Sustained High Levels of Both Total and High Molecular Weight Adiponectin in Plasma during the Convalescent Phase of Haemorrhagic Fever with Renal Syndrome Are Associated with Disease Severity Cardiovascular risk and dietary sugar intake: is the link so sweet?Adipokines and thrombosis.Platelet activation in obesity and metabolic syndrome.The microcirculation in adipose tissue inflammation.

P2860

Q26821925-5E4A0040-6FE9-488E-A0A4-2F2A7A444184 Q26998555-417D1EAB-D745-42A0-A3D6-DEB16DDF3168 Q28082685-AF56544A-4C8F-4BF1-BAA4-F218F2B37C04 Q30358456-04F11772-621C-43B5-898D-EAB2F0C3B0B8 Q33577630-530CE634-5124-4AFF-8F37-FA65EE7E2B85 Q33843417-BA8B280D-8DC7-4490-93EC-BEF451AA40A5 Q33897327-2182943F-6C55-4A5C-A3C4-30FB37B395FA Q34002877-8947E274-34CD-497F-993C-679976639A17 Q34109255-DF2814B8-ADE4-4C6B-9D7E-3D4E4879822F Q35023196-10DE50DD-1881-40A6-9D64-B38F721E5BE4 Q35063642-E134F0C7-183E-400A-9213-AAF7FAB903BE Q35268971-4A38F097-843C-4798-B930-A9039B90D05A Q35316632-E0946E93-7482-4104-B1CE-069EE8DAE859 Q35535235-38AA83C8-0618-4458-BAB6-FDE131D93EF2 Q35690575-8450F737-6A8E-475E-8A89-C114320E20AB Q35763433-DE9D265F-804D-4D3B-8EAB-9B74A6214DB9 Q36347695-4B83B78F-757C-4E4D-9E3A-6DEB4B257819 Q36382360-0F4345A1-0193-44DB-94D2-2C880EE1E940 Q36454417-A5F9E55E-8DEB-486D-852D-A2F66019A12E Q36539480-39130107-B352-4F77-9275-1773B240FAB9 Q36594283-D5F49C28-2DF2-4726-929F-793106A2A642 Q36634314-74628527-F701-4935-8D6B-C34E5388202F Q36877056-CF038029-0B96-4D2C-B92F-5DFA0A3BC58F Q37041935-668DB9FD-9B10-4158-9D7A-D5E45B1D6855 Q37097126-402917AE-3E4E-4FF6-9466-C1B1D40B841A Q37223566-F8C4E120-A96D-4C03-BE5C-7B71A0BC3EF5 Q37233419-62933980-2138-4469-B9B4-6DDFB41429EF Q37325024-9C440822-DFD0-4DD8-BAFD-35BCC47E7269 Q37338105-EFFEF9B8-40C5-42E6-A7A9-CC0F86DF3735 Q37413267-47B86C46-5CBF-4D80-924B-B53B96974376 Q37496314-D5662597-1761-482D-986A-D5F70BDF4460 Q37635748-C7DA076B-A2F9-486D-A79E-C30C2D038FE2 Q37639726-2E87BA92-4B29-4418-B095-EA4ACF28AD97 Q37710228-4C14CA5B-9C2D-438B-8229-2B6837AED3C7 Q37725468-500F3DCA-3038-4C10-9B0B-E7BF672776F0 Q37739296-E0447222-DA56-4CE6-84F4-3EC415BD566B Q37872223-5679CD6C-BA60-4D7E-A5EF-A3AD3357EFBE Q37919150-445A90AC-3632-4EAC-8CD0-EC5D3C376142 Q37932076-349EBF3C-3C23-48D7-9032-456D2A520C5F Q38078880-9694CFF7-6EAC-41B4-BF01-1582D29AAEB5

P2860

Adiponectin acts as an endogenous antithrombotic factor.

http://www.wikidata.org/entity/Q33226568

description

2005 nî lūn-bûn

@nan

2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Adiponectin acts as an endogenous antithrombotic factor.

@ast

Adiponectin acts as an endogenous antithrombotic factor.

@en

type

label

Adiponectin acts as an endogenous antithrombotic factor.

@ast

Adiponectin acts as an endogenous antithrombotic factor.

@en

prefLabel

Adiponectin acts as an endogenous antithrombotic factor.

@ast

Adiponectin acts as an endogenous antithrombotic factor.

@en

P1433

Q33226568-0165C2E2-5243-402B-B2BB-8EFE74EC2481

P1476

Q33226568-2EE9E410-C99A-43A8-86CE-69454CB30BD6

P2093

Q33226568-34F50CF0-083B-437C-BD11-2A7473E1ED9A

Q33226568-3D9ED4FA-44C5-448B-8673-637CCA3D5BBB

Q33226568-412258C6-FB5C-4D6D-B3BF-76F731C0AEB5

Q33226568-6AA83F0E-4688-4635-B5C4-1E374BB905F1

Q33226568-7CBF1485-2009-4E43-A67E-AD3E540488CD

Q33226568-9D13F9FD-97F6-418B-A8C1-5490F8D42698

Q33226568-9ED62B85-928A-450D-B46E-D4AD0986B2E8

Q33226568-AB4573DB-7671-46AA-8D73-0A09C3775562

Q33226568-B53482A4-B386-48AB-B1FB-085AB76224B4

Q33226568-BD4EFC9A-3F25-43C0-90C4-389167F67A97

P304

Q33226568-14412537-AF04-4B44-BCE6-2AB010E9DB56

P31

Q33226568-AC98387B-5E69-4634-B84B-CA6C3449B2EC

P356

Q33226568-1C92809C-DB85-4BE9-A8F5-1D1E63C0AF45

P407

Q33226568-2D7BDA68-070D-4133-8B2B-E29D9DFE2F92

P433

Q33226568-AB577422-8500-4D52-AE44-26239F0A009F

P478

Q33226568-98FACD69-B85B-4FFF-A9B6-0571AAF08349

P577

Q33226568-7D0B183D-CEBA-41AC-85E3-BF64C04DA66A

P698

Q33226568-6C6AAF12-A9AC-43EA-914F-6017C0456017

P356

01.ATV.0000194076.84568.81

P1433

Arteriosclerosis, Thrombosis, and Vascular Biology

P1476

Adiponectin acts as an endogenous antithrombotic factor.

@en

P2093

Hidetoshi Ujiie

http://www.w3.org/2001/XMLSchema#string

Hirokazu Kashiwagi

http://www.w3.org/2001/XMLSchema#string

Hisashi Kato

http://www.w3.org/2001/XMLSchema#string

Iichiro Shimomura

http://www.w3.org/2001/XMLSchema#string

Junichiro Yamamoto

http://www.w3.org/2001/XMLSchema#string

Masamichi Shiraga

http://www.w3.org/2001/XMLSchema#string

Norikazu Maeda

http://www.w3.org/2001/XMLSchema#string

Seiji Tadokoro

http://www.w3.org/2001/XMLSchema#string

Shigeki Miyata

http://www.w3.org/2001/XMLSchema#string

Shigenori Honda

http://www.w3.org/2001/XMLSchema#string

P304

224-230

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.ATV.0000194076.84568.81

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2005-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16269667

http://www.w3.org/2001/XMLSchema#string